# Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA)

> **NCT07484035** · NA · NOT_YET_RECRUITING · sponsor: **Heilongjiang Feihe Dairy Co. Ltd.** · enrollment: 124 (estimated)

## Conditions studied

- Cow's Milk Protein Allergy (CMPA)

## Interventions

- **OTHER:** Feihe Extensively Hydrolyzed Formula
- **OTHER:** Nestlé Extensively Hydrolyzed Formula

## Key facts

- **NCT ID:** NCT07484035
- **Lead sponsor:** Heilongjiang Feihe Dairy Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-05
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07484035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07484035, "Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07484035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*